Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 150 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Dusquetide for chemoradiation-induced oral mucositis in patients with squamous cell carcinoma of the head and neck	Dusquetide (SGX942)	Chemoradiation-induced oral mucositis	Dental and Oral Health , Head and Neck Cancer , Toxicology	2020	View \| Download
Edasalonexent for Duchene muscular dystrophy	Edasalonexent (CAT-1004)	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2020	View \| Download
Eladocagene exuparvovec for aromatic l-amino acid decarboxylase deficiency	Eladocagene Exuparvo (Upstaza) for Aromatic L-amino acid decarboxylase (AADC) deficiency	Aromatic L-amino acid decarboxylase (AADC) deficiency	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation in patients aged 12 years old and older	Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Tezacaftor (VX-661)	Cystic fibrosis	Genetic Disorders , Respiratory System	2020	View \| Download
Empagliflozin for treatment of chronic heart failure with reduced ejection fraction	Empagliflozin (Jardiance; DINAMO)	Heart failure (HF)	Cardiovascular System	2020	View \| Download
Enfortumab vedotin for locally advanced or metastatic urothelial cancer	Enfortumab vedotin (ASG-22ME; Padcev)	Urothelial cancer	Urological Cancer	2020	View \| Download
Eptinezumab for prevention of Migraine	Eptinezumab (ALD403)	Migraine	Neurology	2020	View \| Download
Eryaspase in addition to chemotherapy for treating advanced or metastatic pancreatic cancer – second-line	Eryaspase (Graspa; ERY001) , FOLFOX4 , Gemcitabine (Gemzar; gemcitabine hydrochloride)	Pancreatic cancer	Gastrointestinal Cancer	2020	View \| Download
Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B	Etranacogene Dezaparvovec (AMT-061; AAV5-hFIXco-Padua)	Haemophilia B	Haematology	2020	View \| Download
Etrolizumab for treating moderately to severely active ulcerative colitis in adults	Etrolizumab (PRO145223; RG7413; rhuMAb Beta7)	Ulcerative colitis	Gastroenterology	2020	View \| Download